These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10430510)

  • 1. No influence of presenilin1 I143T and G384A mutations on endogenous tau phosphorylation in human and mouse neuroblastoma cells.
    Julliams A; Vanderhoeven I; Kuhn S; Van Broeckhoven C; De Jonghe C
    Neurosci Lett; 1999 Jul; 269(2):83-6. PubMed ID: 10430510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143T and G384A mutations.
    Vanderhoeven I; Cras P; Martin JJ; Van Broeckhoven C; De Jonghe C
    Neurosci Lett; 1999 Oct; 274(3):183-6. PubMed ID: 10548420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.
    Van Gassen G; De Jonghe C; Nishimura M; Yu G; Kuhn S; St George-Hyslop P; Van Broeckhoven C
    Mol Med; 2000 Jul; 6(7):570-80. PubMed ID: 10997338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
    Irving NG; Miller CC
    Neurosci Lett; 1997 Jan; 222(2):71-4. PubMed ID: 9111731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis.
    Mutoh T; Kawamura N; Hirabayashi Y; Shima S; Miyashita T; Ito S; Asakura K; Araki W; Cazzaniga E; Muto E; Masserini M
    FASEB J; 2012 Jul; 26(7):3065-74. PubMed ID: 22508690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
    Soto-Mercado V; Mendivil-Perez M; Velez-Pardo C; Lopera F; Jimenez-Del-Rio M
    PLoS One; 2020; 15(5):e0221669. PubMed ID: 32437347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt activity in presenilin 1 wild-type and mutation transfected human SH-SY5Y neuroblastoma cells after serum deprivation and high glucose stress.
    Vestling M; Wiehager B; Tanii H; Cowburn RF
    J Neurosci Res; 2001 Nov; 66(3):448-56. PubMed ID: 11746362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1.
    Boutajangout A; Leroy K; Touchet N; Authelet M; Blanchard V; Tremp G; Pradier L; Brion JP
    Neurosci Lett; 2002 Jan; 318(1):29-33. PubMed ID: 11786218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JB
    Curr Alzheimer Res; 2015; 12(8):745-51. PubMed ID: 26159201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.
    Hamano T; Mutoh T; Tabira T; Araki W; Kuriyama M; Mihara T; Yano S; Yamamoto H
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):70-6. PubMed ID: 15950763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of okra (Abelmoschus esculentus Linn.) on the cellular events associated with Alzheimer's disease in a stably expressed HFE neuroblastoma SH-SY5Y cell line.
    Mairuae N; Connor JR; Lee SY; Cheepsunthorn P; Tongjaroenbuangam W
    Neurosci Lett; 2015 Aug; 603():6-11. PubMed ID: 26170247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.
    Theuns J; Del-Favero J; Dermaut B; van Duijn CM; Backhovens H; Van den Broeck MV; Serneels S; Corsmit E; Van Broeckhoven CV; Cruts M
    Hum Mol Genet; 2000 Feb; 9(3):325-31. PubMed ID: 10655540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.
    Preuss U; Mandelkow EM
    Eur J Cell Biol; 1998 Jul; 76(3):176-84. PubMed ID: 9716264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of wild-type and mutant familial Alzheimer's disease-associated presenilin-1 in cultured neurons.
    Weihl CC; Ghadge GD; Miller RJ; Roos RP
    J Neurochem; 1999 Jul; 73(1):31-40. PubMed ID: 10386952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo.
    Doglio LE; Kanwar R; Jackson GR; Perez M; Avila J; Dingwall C; Dotti CG; Fortini ME; Feiguin F
    Neuron; 2006 May; 50(3):359-75. PubMed ID: 16675392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.